Company news

Merck KGaA news in 2025

Merck KGaA's news releases, calls and decks from 2025, newest first.

View company

Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor

December 22, 2025

Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders

November 20, 2025

Universal Display Corporation to Acquire Emissive OLED Patent Assets from Merck KGaA, Darmstadt, Germany

November 6, 2025

Merck KGaA, Darmstadt, Germany Signs Long-Term Renewable Energy Contract for South Korea Sites

November 4, 2025

MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies

October 28, 2025

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

October 21, 2025

EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies

October 16, 2025

MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio

October 15, 2025

Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

September 3, 2025

Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

September 2, 2025

Zhejiang-based GNMI Expands Overseas: Hangzhou Becomes a New Starting Point for the China-German Industrial Synergies

September 1, 2025

Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders

August 18, 2025

MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration

July 24, 2025

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

July 18, 2025

MilliporeSigma Launches AAW™ Workstation to Advance Lab Automation

July 15, 2025

Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

July 1, 2025

MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

June 18, 2025

Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

April 28, 2025

Calls in 2025

Decks in 2025